Hatchtech Drug Patent Portfolio
Hatchtech owns 1 orange book drug protected by 5 US patents Given below is the list of Hatchtech's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10292389 | Pediculicidal composition | 17 Dec, 2034 | Active |
| US7812163 | Methods and compositions for controlling ectoparasites | 28 Oct, 2026 | Active |
| US8212038 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
| US9357783 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
| US9839631 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
Latest Legal Activities on Hatchtech's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hatchtech.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 03 May, 2024 | US7812163 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US8212038 |
|
Email Notification
Critical
| 03 May, 2024 | US9357783 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US7812163 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US9357783 |
|
Email Notification
Critical
| 03 May, 2024 | US9839631 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US9839631 |
|
Email Notification
Critical
| 03 May, 2024 | US8212038 |
|
Email Notification
Critical
| 18 Apr, 2024 | US10292389 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 18 Apr, 2024 | US10292389 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Apr, 2024 | US10292389 |
|
Email Notification
Critical
| 02 Apr, 2024 | US10292389 |
|
Patent Term Extension Certificate
Critical
| 11 Mar, 2024 | US7812163 |
|
Withdrawal of Application for PTE
Critical
| 07 Mar, 2024 | US8212038 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 03 Jan, 2024 | US8212038 |
Hatchtech's Family Patents
Hatchtech Drug List
Given below is the complete list of Hatchtech's drugs and the patents protecting them.
1. Xeglyze
Xeglyze is protected by 5 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10292389 | Pediculicidal composition |
17 Dec, 2034
(10 years from now)
| Active |
| US7812163 | Methods and compositions for controlling ectoparasites |
28 Oct, 2026
(2 years from now)
| Active |
| US8212038 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(3 months ago)
| Expired |
| US9357783 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(3 months ago)
| Expired |
| US9839631 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(3 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xeglyze's drug page